P/E ratio for SurgePays (SURG)

P/E ratio history for SurgePays from 2018 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
STAAR Surgical STAA	59.1	2,804.68%	🇺🇸 USA
Integra LifeSciences IART	17.9	778.30%	🇺🇸 USA
Cooper Companies COO	16.8	724.50%	🇺🇸 USA
Stryker Corporation SYK	53.5	2,531.58%	🇺🇸 USA
Johnson & Johnson JNJ	10.3	404.15%	🇺🇸 USA
Novartis NVS	26.0	1,176.26%	🇨🇭 Switzerland
CONMED CNMD	36.1	1,675.45%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.